| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| George Magrath | CEO | 2026-11-03 | 28,258 | $3.90 | $110.18kSell |
| Benjamin R. Yerxa | Pres | 2026-10-23 | 7,669 | $3.55 | $27.23kSell |
| George Magrath | CEO | 2026-10-23 | 9,591 | $3.59 | $34.38kSell |
| Benjamin R. Yerxa | Pres | 2026-10-23 | 25,520 | $3.53 | $90.14kSell |
| Joseph K. Schachle | COO | 2026-10-23 | 4,767 | $3.57 | $16.99kSell |
| Robert E. Gagnon | CFO | 2026-10-23 | 14,000 | $3.55 | $49.64kSell |
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | 2026-09-30 | 556,000 | $4.96 | $2.76MSell |
| George Magrath | CEO | 2026-09-09 | 392,157 | $1.15 | $450.98kBuy |
| George Magrath | CEO | 2026-09-09 | 75,541 | $5.97 | $450.98kSell |
| Cam Gallagher | Director | 2026-09-08 | 784,314 | $1.15 | $901.96kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sungkee Chung | 169.47% | 163,800,000 | $668.30M | Insider |
| Sung Sook Park | 72.63% | 70,200,000 | $286.42M | Insider |
| Frank Ferraro | 26.90% | 26,000,000 | $106.08M | Insider |
| Inok Ahn | 14.48% | 14,000,000 | $57.12M | Insider |
| Chang Ho Ahn | 11.91% | 11,510,000 | $46.96M | Insider |
| Rexgene Biotech Co Ltd | 5.70% | 5,505,956 | $22.46M | Insider |
| Foundation Fighting Blindness Retinal Degeneration Fund | 3.35% | 3,236,171 | $13.20M | Insider |
| Cam Gallagher | 3.07% | 2,966,111 | $12.10M | Insider |
| Young Soon Park | 2.80% | 2,706,500 | $11.04M | Insider |
| George Magrath | 2.08% | 2,010,636 | $8.20M | Insider |